Quotient Limited Announces Pricing of Underwritten Offering
24 juin 2022 08h28 HE
|
Quotient Limited
JERSEY, Channel Islands, June 24, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of an underwritten...
Quotient Limited Provides Fourth Quarter Fiscal 2022 Results and Business Update
24 juin 2022 07h00 HE
|
Quotient Limited
Financial Position Amended Secured Notes: Reduces the company’s cash obligations by approximately $93 million over the next 36 monthsAnnounces Public Equity Offering: Improving liquidity runwayFY...
Quotient Limited Announces Proposed Amendments to Senior Secured Notes
23 juin 2022 18h08 HE
|
Quotient Limited
JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced that in connection with the public...
Quotient Limited Announces Proposed Underwritten Offering
23 juin 2022 17h55 HE
|
Quotient Limited
JERSEY, Channel Islands, June 23, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (Nasdaq: QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an...
Quotient Limited Reschedules Fourth Quarter and Full Year 2022 Financial Results Announcement to Friday, June 24th and Provides a Preview of Financials
21 juin 2022 16h56 HE
|
Quotient Limited
Pre-announces FY 2022 revenue of $38.5 millionSecured $1.4 million of orders in Q1 FY23 for recently CE Marked Extended IH MosaiQ Solution$83.2 million in cash and investments as of March 31, 2022 ...
Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd
17 juin 2022 07h02 HE
|
Quotient Limited
JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth...
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
08 juin 2022 06h44 HE
|
Quotient Limited
Partnership brings together novel technology and clinical applications expertise to produce automated, multiplexed solutions for advancing autoimmune diagnosticsExpands access to $2 billion autoimmune...
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
17 mai 2022 09h17 HE
|
Quotient Limited
Diversified global presence key to Company's go-to-market strategyStrengthened geographical expansion with distributor strategy model to better support customers in the region JERSEY, Channel...
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
12 mai 2022 08h30 HE
|
Quotient Limited
Virtual event on Monday, May 23rd at 11:00 AM ETThe webinar will provide a detailed discussion on the current landscape and unmetneeds within blood grouping and donor disease screening JERSEY,...
Quotient Limited Announces Appointment of New Board Member
26 avr. 2022 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the appointment of Thomas Aebischer to Quotient...